Andrew Hessel is a futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the rapid changes happening in life science. He is a Distinguished Researcher with Autodesk Inc. in their SF-based Life Sciences group, which is creating software tools for molecular and living systems. He is also the co-founder of Humane Genomics, which is developing virus-based therapies for cancer, starting with dogs.